1 |
Tebb AJ, Arteaga A, Evans H, Ramsey IK. Canine hyperadrenocorticism: effects of trilostane on parathyroid hormone, calcium and phosphate concentrations. J Small Anim Pract 2005; 46: 537-542.
DOI
|
2 |
Touart DM, Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol 1998; 39: 527-544.
DOI
|
3 |
Zur G, White SD. Hyperadrenocorticism in 10 dogs with skin lesions as the only presenting clinical signs. J Am Anim Hosp Assoc 2011; 47: 419-427.
DOI
|
4 |
Hsu K, Snead E, Davies J, Carr A. Iatrogenic hyperadrenocorticism, calcinosis cutis, and myocardial infarction in a dog treated for IMT. J Am Anim Hosp Assoc 2012; 48: 209-215.
DOI
|
5 |
Huang HP, Yang HL, Liang SL, Lien YH, Chen KY. Iatrogenic hyperadrenocorticism in 28 dogs. J Am Anim Hosp Assoc 1999; 35: 200-207.
DOI
|
6 |
Miller Jr. WH, Griffin CE, Campbell KL. Neoplastic and non-Neoplastic Tumors. In: Muller and Kirk's small animal dermatology, 7th ed. St. Louis: Elsevier. 2013: 831-832.
|
7 |
Muller A, Degorce-Rubiales F, Guaguere E. Metastatic calcinosis (including calcinosis cutis) in a young dog with multiple urinary tract abnormalities. Vet Dermatol 2011; 22: 279-283.
DOI
|
8 |
Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
DOI
|
9 |
Plumb DC. Minocycline HCl. In: Plumb's veterinary drug handbook, 7th ed. Iowa: Wiley-Blackwell. 2011: 937-939.
|
10 |
Perret L, Tait CP. Non-antibiotic properties of tetracyclines and their clinical application in dermatology. Australas J Dermatol 2014; 55: 111-118.
DOI
|
11 |
Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E. Calcinosis cutis: part II. Treatment options. J Am Acad Dermatol 2011; 65: 15-22.
DOI
|
12 |
Robertson LP, Marshall RW, Hickling P. Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis 2003; 62: 267-269.
DOI
|
13 |
Santavirta S, Takagi M, Konttinen YT. Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother 1996; 40: 244-246.
|
14 |
Sapadin AN, Fleischmajer R. Tetracycline: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54: 258-265.
DOI
|
15 |
Cohen H, Solomon V, Alferiev IS, Bruer E, Ornoy A, Patlas N, Eidelman N, Hagele G, Golomb G. Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders. Phar Res 1998; 15: 606-613.
DOI
|
16 |
Ahrens FA, Martin RJ. Antimicrobial drugs. In: Hsu WH ed. Handbook of veterinary pharmacology. Iowa: Wiley-Blackwell. 2008; 357-385.
|
17 |
Beale KM, Morris DO. Treatment of canine calcinosis cutis with dimethylsulfoxide gel. Proc Annu Memb Meet Am Acad Vet Dermatol /Am Coll Vet Dermatol 1998; 14: 97.
|
18 |
Cho NY, Cho DH, Choi HJ, Jeong SM, Lee YW, Park SJ. Clinical trial of diltiazem on dystrophic calcinosis cutis in a dog. Korean J Vet Res 2013; 53:181-184.
DOI
|
19 |
Doerr KA, Outerbridge CA, White SD, Kass PH, Shiraki R, Lam AT, Affolter VK. Calcinosis cutis in dogs: histopathological and clinical analysis of 46 cases. Vet Dermatol 2013; 24: 355-361.
DOI
|
20 |
Frazier KS, Hullinger GA, Liggett AD, Hines ME 2nd. Multiple cutaneous metaplastic ossification associated with iatrogenic hyperglucocorticoidism. J Vet Diagn Invest 1998; 10: 303-307.
DOI
|
21 |
Gross TL, Ihrke PJ, Walder EJ. Degenerative, dysplastic and depositional diseases of dermal connective tissue. In: Skin diseases of the dog and cat: clinical and histopathologic diagnosis, 2nd ed. Oxford: Blackwell Science Ltd. 2005: 373-377.
|